Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1315
-
Total 13F shares, excl. options
-
93.9M
-
Shares change
-
+2.35M
-
Total reported value, excl. options
-
$98.7B
-
Value change
-
+$2.5B
-
Put/Call ratio
-
1.43
-
Number of buys
-
640
-
Number of sells
-
-506
-
Price
-
$1,051.03
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2024
1,472 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2024.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,315 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.9M shares
of 105M outstanding shares and own 89.47% of the company stock.
Largest 10 shareholders include FMR LLC (10.6M shares), VANGUARD GROUP INC (8.99M shares), BlackRock Inc. (8.45M shares), JPMORGAN CHASE & CO (8.28M shares), STATE STREET CORP (4.84M shares), Capital World Investors (4.64M shares), Capital International Investors (3.13M shares), GEODE CAPITAL MANAGEMENT, LLC (2.42M shares), Dodge & Cox (2.32M shares), and FRANKLIN RESOURCES INC (1.92M shares).
This table shows the top 1315 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.